225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Lymphoblastic Leukemia · Acute Myeloid Leukemia · Myelodysplastic Syndrome

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • City of Hope Medical Center, Duarte, California, United States

    Contact: Study coordinator (Jeffrey Y. Wong) · jwong@coh.org · 626-218-2247
    Contact: Principal Investigator (Jeffrey Y. Wong)
Study leads
  • Jeffrey Y Wong

    Principal Investigator

    City of Hope Medical Center